Published in the European Journal of Heart Failure1, results from a new sub-analysis of the RE-LY®* trial demonstrate important benefits...
Read moreNew data on an emerging treatment that aims to fight colorectal cancer by stimulating the immune system have been presented...
Read moreThe U.S. Food and Drug Administration, in partnership with international regulatory and law enforcement agencies, took action this week against...
Read moreA promising new treatment for breast cancer being developed at Virginia Commonwealth University Massey Cancer Center and the VCU Institute...
Read moreThe U.S. Food and Drug Administration announced that the U.S. is now a "listed" countrydisclaimer icon with the European Commission...
Read moreAspirin is known to lower risk for some cancers, and a new study led by a UC San Francisco scientist...
Read moreAstraZeneca announced that MedImmune, its global biologics research and development arm, and NGM Biopharmaceuticals, Inc. have entered into an exclusive...
Read moreA phase 1 clinical trial for the first treatment to reset the immune system of multiple sclerosis (MS) patients showed...
Read moreBristol-Myers Squibb Company and AstraZeneca announced that the U.S. Food and Drug Administration (FDA) has accepted and granted a Priority...
Read moreInjectable nanoparticles developed at Massachusetts Institute of Technology (MIT) may someday eliminate the need for patients with Type 1 diabetes...
Read more
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
